InvestorsHub Logo
Post# of 252188
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 127573

Monday, 11/14/2011 8:46:50 AM

Monday, November 14, 2011 8:46:50 AM

Post# of 252188

Pending presentation of the full dataset from this study

It's out:

Bayer’s Xarelto® (Rivaroxaban) Meets Primary Efficacy Endpoint and Shows Significant Reduction in Mortality in Major ACS Study

http://www.press.bayer.com/baynews/baynews.nsf/ID/1BB516127D005F31C125794700400491

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.